Last reviewed · How we verify
NCT05924542
Kelaa Mental Resilience App for Employees
NA trial testing Kelaa Mental Resilience App in Stress in 678 participants. Completed in 24 September 2018.
24 September 2018
Quick facts
| Lead sponsor | University of Wuerzburg |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 678 |
| Start date | 15 January 2018 |
| Primary completion | 24 September 2018 |
| Estimated completion | 24 September 2018 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Kelaa Mental Resilience App
Conditions studied
- Stress — all drugs for Stress →
- Presenteeism — all drugs for Presenteeism →
- Absenteeism — all drugs for Absenteeism →
Sponsor
University of Wuerzburg
Who can join
Adults 18 to 65, any sex, with Stress or Presenteeism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this randomized control trial is to detect and prevent work-related psychological stress among European workers early on, aiming to mitigate its adverse health consequences, including burnout and depression. Soma Analytics has developed a smartphone-based system that comprises a diagnostic module utilizing smartphone sensors to collect and analyze stress biomarkers and an interventional module to reduce stress levels. The main questions this study aims to answer are: * Hypothesis 1: Compared to the waitlist control, after using the app for 4 weeks, participants in the app group will report (a) lower levels of stress (cognitive and general), (b) higher levels of wellbeing, (c) higher levels of resilience, and (d) fewer sleeping troubles. * Hypothesis 2: The observed effects will be more intense the more the user interacts with the app throughout the duration of the study. Participants (employees from six organizations in three European countries) will use the app for 4 weeks. Their levels of stress, well-being, resilience, and sleeping troubles are assessed at baseline, after 2 weeks (mid-intervention), 4 weeks (end of intervention), and 6 weeks (follow-up). Researchers will compare the intervention group with the waitlist control group to see if levels of stress, well-being, resilience, and sleeping troubles change over time.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Mediating Role of General and Cognitive Stress on the Effect of an App-Based Intervention on Productivity Measures in Workers: Randomized Controlled Trial.
de Miquel C, Moneta MV, Weber S, Lorenz C, et al · · 2023 · PMID 37399056 · DOI 10.2196/42317
Verify or expand the search:
- PubMed search for NCT05924542
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stress
Currently open trials in the same condition.
- NCT07485790 — The Effects of Yoga on Pregnant Women · NA · recruiting
- NCT07469527 — Effects of Feel Free® Classic Tonic on Stress and Pharmacokinetics in Healthy Adults · NA · recruiting
- NCT07387107 — Decreasing Stress Via Virtual Reality and Binaural Beats in Non-Clinical Adults · NA · recruiting
- NCT07240792 — Development of a College Student-Delivered Cognitive-Behavioral Therapy (CBT) Intervention for Rural High School Student · NA · recruiting
- NCT07518056 — Relationships Between Nomophobia Levels and Perceived Stress, Body Image and Food Addiction Among University Students · recruiting
Other University of Wuerzburg trials
Trials by the same sponsor.
- NCT06890052 — Effects of Isolated Lumbar Extension Resistance Training Alone and in Combination with General Exercise and Manual Thera · NA · active not recruiting
- NCT05585593 — Registry for Hypoparathyroidism Wuerzburg · recruiting
- NCT03437174 — Burden of Illness in Hypoparathyroidism · completed
- NCT01352403 — Severe Obesity: Bariatric Surgery vs. Life-Style-Intervention · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05924542 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Wuerzburg
- Last refreshed: 29 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05924542.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing